share_log

HC Wainwright & Co. Initiates Coverage On Sensei Biotherapeutics With Buy Rating, Announces Price Target of $4

Benzinga ·  Dec 4, 2023 06:41

HC Wainwright & Co. analyst Edward White initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment